Related Experiment Video
Updated: Jul 15, 2026
10:17
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
The Finnish legislation on workplace drug testing
Matti E Lamberg1, Raila Kangasperko, Ritva Partinen
1Ministry of Social Affairs and Health, PB 33, FIN-00023 Government, Helsinki, Finland. matti.lamberg@stm.fi
Forensic Science International
|May 15, 2007
Summary
Finland
Area of Science:
- Occupational Health Law
- Workplace Drug Testing Regulations
Background:
- Finland's 2004 Act on the Protection of Privacy in Working Life governs employer access to employee drug use information.
- Amendments to the Occupational Health Care Act mandate workplace drug and alcohol programs.
Purpose of the Study:
- To outline the legal framework for workplace drug testing in Finland.
- To detail requirements for drug-free workplace policies and procedures.
Main Methods:
- Analysis of Finnish legislation including the Act on the Protection of Privacy in Working Life and the Occupational Health Care Act.
- Review of the Government decree on drug use testing (218/2005).
Main Results:
- Employers can process drug use information under specific conditions.
- Workplaces must implement written drug and alcohol programs developed collaboratively.
- A Government decree specifies practical aspects of drug testing, ensuring quality and privacy.
Conclusions:
- Finnish law provides a comprehensive framework for managing workplace drug use.
- Legislation aims to balance employer needs with employee privacy and fundamental rights in drug testing.
Related Concept Videos
01:25Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
01:03Drug Control Governance: Regulatory Bodies and Their Impact
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...
01:23Toxicity Testing in Animals
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
01:15Drug Abuse and Addiction: Pharmacological Phenomena
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...